A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)

PHASE3UnknownINTERVENTIONAL

Enrollment

454

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2024

Conditions

Advanced Breast Cancer

Interventions

DRUG

SYHX2011

IV infusion, 260 mg/m\^2

DRUG

Paclitaxel for injection (albumin-bound)

IV infusion, 260 mg/m\^2

Trial Locations (1)

The Fourth Hospital of Hebei Medical University, Shijiazhuang